Breaking News Instant updates and real-time market news.

OXY

Occidental Petroleum

$71.30

0.34 (0.48%)

, MPLX

MPLX

$32.08

0.21 (0.66%)

07:30
12/16/16
12/16
07:30
12/16/16
07:30

Unusual put flow in option market yesterday

Notable put activity was cited Thursday in Occidental Petroleum (OXY), MPLX (MPLX), and Sage Therapeutics (SAGE).

OXY

Occidental Petroleum

$71.30

0.34 (0.48%)

MPLX

MPLX

$32.08

0.21 (0.66%)

SAGE

SAGE Therapeutics

$48.99

1.04 (2.17%)

OXY Occidental Petroleum
$71.30

0.34 (0.48%)

08/05/16
DBAB
08/05/16
DOWNGRADE
Target $79
DBAB
Hold
Occidental Petroleum downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Ryan Todd downgraded Occidental Petroleum (OXY) to Hold saying he sees limited drivers of outperformance from current share levels. Moderate crude leverage to a recovery and a dividend/funding gap leaves little available cash flow to accelerate activity, Todd tells investors in a research note. The analyst has a $79 price target for Occidental. He coupled the downgrade with an upgrade of EOG Resources (EOG) to Buy.
10/05/16
MZHO
10/05/16
INITIATION
Target $83
MZHO
Buy
Occidental Petroleum initiated with a Buy at Mizuho
Mizuho analyst Timothy Rezvan initiated Occidental Petroleum with a Buy and a $83 price target.
09/12/16
JPMS
09/12/16
DOWNGRADE
Target $78
JPMS
Underweight
Occidental Petroleum downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Phil Gresh downgraded Occidental Petroleum (OXY( to Underweight saying the valuation is stretched. The stock at current levels fully reflects the company's growth and balance sheet benefits, Gresh tells investors in a research note. He upped his price target for the shares to $78 from $77. Gresh this morning also upgraded ConocoPhillips (COP) to Overweight.
12/16/16
GSCO
12/16/16
UPGRADE
Target $75
GSCO
Neutral
Occidental Petroleum upgraded to Neutral from Sell at Goldman
Goldman analyst Brian Singer upgraded Occidental Petroleum to Neutral and raised its price target to $75 from $70 citing share underperformance and potential clarity on Permian potential.
MPLX MPLX
$32.08

0.21 (0.66%)

11/01/16
UBSW
11/01/16
UPGRADE
Target $44
UBSW
Neutral
Marathon Petroleum upgraded to Neutral from Sell at UBS
UBS analyst Spiro Dounis upgraded Marathon Petroleum to Neutral citing the company's newly announced plans to unlock value in the General Partner and accelerate growth at the MLP. The analyst estimates the General Partner interest in MPLX (MPLX) could be worth $4.6B-$4.8B. He raised his price target for Marathon Petroleum to $44 from $38.
10/31/16
RAJA
10/31/16
UPGRADE
RAJA
Strong Buy
MPLX upgraded to Strong Buy from Market Perform at Raymond James
Raymond James upgraded MPLX (MPLX) two notches to Strong Buy from Market Perform citing the dropdown profile from Marathon Petroleum (MPC) announced last week, combined with the increasing likelihood that the long-term cost of capital concerns of the partnership will be rectified, he believes the current risk/reward appears increasingly positive.
10/31/16
JEFF
10/31/16
UPGRADE
Target $40
JEFF
Buy
MPLX upgraded to Buy from Hold at Jefferies
Jefferies analyst Corey Goldman upgraded MPLX (MPLX) to Buy after Marathon Petroleum (MPC) said it is evaluating options to highlight its MPLX GP value and optimize MPLX's cost of capital. The analyst expects this to result in an accelerated MPLX drop-down schedule. He raised his price target for MPLX and $40 from $35. Goldman also upped his price target for Marathon Petroleum to $59 and keeps a Buy rating on the name.
12/08/16
EVER
12/08/16
UPGRADE
Target $39
EVER
Buy
MPLX upgraded to Buy from Hold at Evercore ISI
Evercore ISI analyst Timm Schneider upgraded MPLX to Buy and raised its price target to $39 from $27. The analysts' updated forecasts assumes an accelerated drop-down schedule and IDR buyout, paving the way for a fair compromise between both activist investors and management.
SAGE SAGE Therapeutics
$48.99

1.04 (2.17%)

12/01/16
WBLR
12/01/16
NO CHANGE
WBLR
Celgene, Zoetis among top healthcare picks at William Blair
William Blair analysts named their top health care picks for 2017, identifying Evolent Health (EVH) as their top HC Services and HC IT pick, Zoetis (ZTS) as their top dental and animal health pick,and Pacific Biosciences (PACB) as their top diagnostic services and life sciences choice, The firm identified ARIAD (ARIA), Celgene (CELG) and SAGE Therapeutics (SAGE) as their top biotech choices. It named Edwards Lifesciences (EW), Nevro (NVRO), and K2M Group (KTWO) as its favorite med tech picks.
12/14/16
RAJA
12/14/16
UPGRADE
Target $84
RAJA
Strong Buy
SAGE Therapeutics upgraded to Strong Buy at Raymond James
As previously reported, Raymond James upgraded Sage Therapeutics to Strong Buy from Buy. Analyst Christopher Raymond said yesterday's R&D event provided an in-depth look at the breadth of the platform and the progress to date. Eight clinical readouts are expected in 2017, with the 1H 2017 STATUS readout in the spotlight, the analyst wrote. He remains encouraged by SAGE's execution, considerable strategic optionality, and thinks at current levels offers a compelling entry point and a positive setup in 2017.
12/14/16
RAJA
12/14/16
UPGRADE
RAJA
Strong Buy
SAGE Therapeutics upgraded to Strong Buy from Outperform at Raymond James
12/07/16
BMOC
12/07/16
NO CHANGE
Target $68
BMOC
Outperform
BMO ups SAGE target to $68 on accelerated depression program
BMO Capital analyst Gary Nachman raised his price target for SAGE Therapeutics to $68 from $57 after the company announced that the ongoing trials for SAGE-547 in postpartum depression will be expanded to qualify as Phase 3, and, if positive, will be sufficient for a new drug application submission. This accelerates the program by about a year, and helps bring forward a key value driver for SAGE, Nachman tells investors in a research note. He raised his estimates for SAGE-547 in postpartum depression by $25M-$150M through 2027. The analyst now expects $350M in sales in 2027. Nachman reiterates an Outperform rating on SAGE, which closed yesterday up $3.86 to $55.68.

TODAY'S FREE FLY STORIES

HCA

HCA Holdings

$87.21

3.16 (3.76%)

, LPNT

LifePoint

$64.85

0.25 (0.39%)

12:31
06/22/17
06/22
12:31
06/22/17
12:31
Hot Stocks
Hospitals, insurers rise after Republicans release draft of ACA replacement bill »

Shares of hospital and…

HCA

HCA Holdings

$87.21

3.16 (3.76%)

LPNT

LifePoint

$64.85

0.25 (0.39%)

THC

Tenet

$19.14

1.455 (8.23%)

CYH

Community Health

$9.60

0.775 (8.79%)

QHC

Quorum Health

$4.43

0.335 (8.19%)

AET

Aetna

$154.14

2.04 (1.34%)

ANTM

Anthem

$194.21

2.14 (1.11%)

CNC

Centene

$82.57

2.45 (3.06%)

CI

Cigna

$172.08

1.895 (1.11%)

HUM

Humana

$240.25

4.04 (1.71%)

MOH

Molina Healthcare

$71.57

1.84 (2.64%)

UNH

UnitedHealth

$187.73

2.81 (1.52%)

WCG

WellCare

$183.58

6.04 (3.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

TECK

Teck Resources

$16.13

0.825 (5.39%)

12:30
06/22/17
06/22
12:30
06/22/17
12:30
Options
Defensive option play in Teck Resources as shares rally »

Defensive option play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$153.91

1.66 (1.09%)

12:22
06/22/17
06/22
12:22
06/22/17
12:22
Hot Stocks
Facebook holds communities event, announces new mission »

Facebook hosted its first…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 19

    Jul

FLR

Fluor

$44.29

0.52 (1.19%)

12:20
06/22/17
06/22
12:20
06/22/17
12:20
Options
Flour calls seeing opening interest »

Flour calls seeing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

12:17
06/22/17
06/22
12:17
06/22/17
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
06/22/17
06/22
12:16
06/22/17
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSIQ

Canadian Solar

$13.99

0.94 (7.20%)

12:10
06/22/17
06/22
12:10
06/22/17
12:10
Options
Notable call buying in Canadian Solar as shares shine »

Notable call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:10
06/22/17
06/22
12:10
06/22/17
12:10
General news
Treasury Option Action: a call 1x2 on 10s »

Treasury Option Action: a…

SRSC

Sears Canada

$0.47

-0.115 (-19.69%)

12:05
06/22/17
06/22
12:05
06/22/17
12:05
Hot Stocks
Breaking Hot Stocks news story on Sears Canada »

Sears Canada trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NLSN

Nielsen

$37.08

-0.15 (-0.40%)

, GOOG

Alphabet

$959.45

8.82 (0.93%)

12:01
06/22/17
06/22
12:01
06/22/17
12:01
Hot Stocks
Nielsen launches mobile measurement for YouTube ads »

Nielsen (NLSN) announced…

NLSN

Nielsen

$37.08

-0.15 (-0.40%)

GOOG

Alphabet

$959.45

8.82 (0.93%)

GOOGL

Alphabet Class A

$978.59

9.6 (0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 19

    Jul

AKS

AK Steel

$6.25

0.055 (0.89%)

12:00
06/22/17
06/22
12:00
06/22/17
12:00
Options
AK Steel Jul 8 calls are today's most active option »

AK Steel Jul 8 calls are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

CVM

CEL-SCI

$1.75

0.0576 (3.41%)

11:58
06/22/17
06/22
11:58
06/22/17
11:58
Hot Stocks
Breaking Hot Stocks news story on CEL-SCI 

Cel Sci trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAIN

Hain Celestial

$33.16

0.13 (0.39%)

11:55
06/22/17
06/22
11:55
06/22/17
11:55
Hot Stocks
Hain Celestial CEO says he has a strong management team backing him »

The Hain Celestial CEO is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 27

    Jun

HAIN

Hain Celestial

$33.16

0.13 (0.39%)

, AMZN

Amazon.com

$1,002.23

9.64 (0.97%)

11:53
06/22/17
06/22
11:53
06/22/17
11:53
Hot Stocks
Hain Celestial says Amazon deal for Whole Foods will give more exposure »

The Hain Celestial CEO is…

HAIN

Hain Celestial

$33.16

0.13 (0.39%)

AMZN

Amazon.com

$1,002.23

9.64 (0.97%)

WFM

Whole Foods

$43.26

0.48 (1.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 27

    Jun

  • 28

    Jun

SPLS

Staples

$8.66

-0.09 (-1.03%)

11:47
06/22/17
06/22
11:47
06/22/17
11:47
Recommendations
Staples analyst commentary  »

Staples intrinsic value…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MMSI

Merit Medical

$36.80

-0.2 (-0.54%)

11:46
06/22/17
06/22
11:46
06/22/17
11:46
Recommendations
Merit Medical analyst commentary  »

Merit Medical allowance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

FSLR

First Solar

$37.23

1.78 (5.02%)

11:45
06/22/17
06/22
11:45
06/22/17
11:45
Options
First Solar call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

ABBV

AbbVie

$72.80

1.455 (2.04%)

11:44
06/22/17
06/22
11:44
06/22/17
11:44
Upgrade
AbbVie rating change  »

AbbVie upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMC

Commercial Metals

$18.47

0.06 (0.33%)

11:38
06/22/17
06/22
11:38
06/22/17
11:38
Hot Stocks
Breaking Hot Stocks news story on Commercial Metals »

Commercial Metals says a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

LPNT

LifePoint

$64.85

0.25 (0.39%)

, CYH

Community Health

$9.56

0.74 (8.39%)

11:35
06/22/17
06/22
11:35
06/22/17
11:35
Hot Stocks
Hosptial stocks at highs after Republicans release ACHA 'discussion draft' »

Publicly traded companies…

LPNT

LifePoint

$64.85

0.25 (0.39%)

CYH

Community Health

$9.56

0.74 (8.39%)

THC

Tenet

$18.94

1.26 (7.13%)

HCA

HCA Holdings

$87.44

3.39 (4.03%)

UHS

Universal Health

$116.28

3.06 (2.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYL

Mylan

$38.27

0.85 (2.27%)

11:26
06/22/17
06/22
11:26
06/22/17
11:26
Periodicals
Mylan investors vote against executive pay, re-elect board members, Reuters says »

Mylan shareholders voted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 13

    Jul

  • 03

    Sep

  • 09

    Oct

11:25
06/22/17
06/22
11:25
06/22/17
11:25
General news
Treasury announced an $88 B package of coupon offerings for next week »

Treasury announced an $88…

V

Visa

$94.25

-0.29 (-0.31%)

11:23
06/22/17
06/22
11:23
06/22/17
11:23
Hot Stocks
Breaking Hot Stocks news story on Visa »

Visa says 'engaged…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

KR

Kroger

$22.12

-0.2542 (-1.14%)

11:21
06/22/17
06/22
11:21
06/22/17
11:21
Hot Stocks
Kroger board approves $1B share repurchase program, raises quarterly dividend »

The Kroger Co.'s…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

V

Visa

$94.21

-0.33 (-0.35%)

11:20
06/22/17
06/22
11:20
06/22/17
11:20
Hot Stocks
Visa says continues to pursue domestic license in China »

Says regulation a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.